Birchview Capital, LP
Birchview Capital, LP reported 79 positions worth $173.1M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: KLAC (18.8%). Biggest move: new buy RARE ($5.6M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | KLAC | $32.5M | 18.80% | 166,938 | — | — | -26.1% | |
| ▸ 2 | BMY | $14.0M | 8.08% | 224,245 | — | — | +0.8% | |
| ▸ 3 | LRCX | $9.9M | 5.69% | 30,000 | — | — | -35.8% | |
| ▸ 4 | Biodesix | $8.6M | 4.94% | 286,804 | — | — | — | |
| ▸ 5 | CORT | $6.4M | 3.67% | 55,200 | — | — | -39.9% | |
| ▸ 6 | OVV | $6.2M | 3.59% | 107,500 | — | — | +12.2% | |
| ▸ 7 | RARE | $5.6M | 3.24% | 373,671 | — | — | +5.8% | |
| ▸ 8 | SLDB | $5.2M | 2.99% | 715,955 | — | — | -5.4% | |
| ▸ 9 | PTGX | $4.9M | 2.85% | 35,000 | — | — | -11.4% | |
| ▸ 10 | PRTA | $3.8M | 2.17% | 449,019 | — | — | -4.9% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Birchview Capital, LP hold as of Q3 2026?
Birchview Capital, LP reported 79 positions worth $173.1M in its Q3 2026 13F filing. Largest positions: KLAC (18.8%), BMY (8.1%), LRCX (5.7%), BIODESIX INC (4.9%) and CORT (3.7%).
What did Birchview Capital, LP buy in Q3 2026?
New positions: RARE, CONTINEUM THERAPEUTICS INC (CTNM) P @ 15.0 01/15/2027, IRLA, VALN and ANNEXON INC (ANNX) P @ 5.0 01/15/2027 (23 in all). Added to: DFTX, XENE, BBIO, ADAGENE INC and VYGR (13 in all).
What did Birchview Capital, LP sell in Q3 2026?
Reduced: BMY, PACB, KLAC, NKTR and LRCX (22 in all). Sold out entirely: VERA, QURE, BIOA, GPCR and NVO (16 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.